tirzepatide glp 1 and gip Tirzepatide's Unique Mechanism of Action - GIP/GLP-1 Dual Agonist Tirzepatide, a dual GIP/GLP-1 receptor

Wegovy is not recommended for people with severe gastroparesis (slow stomach emptying)

Overdose symptoms may include intense upper abdominal pain, which can indicate acute pancreatitis or another serious complication requiring urgent medical evaluation

So far, 36 cases of the eye disorder associated with GLP-1 drugs have been reported on the national database of adverse events, the TGA said

Monitoring requirements for heart failure patients Taking Mounjaro with heart failure requires more frequent monitoring than for people with normal heart function

Metabolic Slowdown: Muscle is metabolically active

Our goal isn't just to help you lose weightit's to transform your relationship with your body for lasting results